Brief: Vivo Cannabis Enters Supply Agreement With Medipharm Labs Australia
19/06/2020 12:16
June 19 (Reuters) - Vivo Cannabis Inc VIVO.TO :
* VIVO CANNABIS™ ENTERS INTO NEW SUPPLY AGREEMENT WITH
MEDIPHARM
LABS AUSTRALIA
* VIVO CANNABIS - MEDIPHARM LABS AUSTRALIA WILL SUPPLY GMP
CERTIFIED FORMULATED CANNABIS OIL PRODUCTS TO BEACON MEDICAL
AUSTRALIA
Source text for Eikon: ID:nCNWfWvwda
Further company coverage: VIVO.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue